• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. L
  4. Lee…
  5. LEE Eunsol
🔗 Permalink
Inventor profile of:

Eunsol LEE

City:

Gyeonggi-do

Country:

South Korea

Published Applications:

4

Last publication date:

2026-04-23

Recent patent applications by LEE Eunsol

Eunsol LEE from Gyeonggi-do, KR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23
US20260108608A1
Human necessities

CD5-TARGETING CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELLS EXPRESSING THE SAME

#2 | 2026-02-19
US20260048084A1
Human necessities

METHODS OF ADMINISTERING NATURAL KILLER CELLS COMPRISING AN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) CHIMERIC ANTIGEN RECEPTOR (CAR)

#3 | 2025-03-06
US20250073264A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME

#4 | 2024-06-06
US20240180962A1
Human necessities

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

InventorID:

6677202 ⎘

  1. Home
  2. Inventor
  3. L
  4. Lee…
  5. LEE Eunsol

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.